Status:
COMPLETED
Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Loss of sense of smell and taste has been anecdotally reported during the covid-19 epidemic. The study investigators wanted to describe the prevalence of olfactory and gustatory dysfunction and assess...
Eligibility Criteria
Inclusion
- Patients presenting with COVID-19 related symptoms including: fever, persistent cough, fatigue, shortness of breath, diarrhoea, abdominal pain, chest pain, sore throat, loss of smell or taste
- Subjects in prolonged contact with COVID-19 infected patients.
Exclusion
- Patients directly admitted to the intensive care unit were excluded
- Patients opposing use of their health data
Key Trial Info
Start Date :
March 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
454 Patients enrolled
Trial Details
Trial ID
NCT04354857
Start Date
March 27 2020
End Date
November 30 2020
Last Update
June 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nimes
Nîmes, France